检索结果 - Gambacorti‐Passerini, Carlo

Refine Results
  1. 1
    How “precise” is precision medicine in hematology?

    How “precise” is precision medicine in hematology? 由 Gambacorti-Passerini, Carlo, Piazza, Rocco

    出版 2017
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  2. 2
    Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019

    Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019 由 Aroldi, Andrea, Chiarle, Roberto, Gambacorti-Passerini, Carlo

    出版 2021
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  3. 3
    Impact of ETNK1 somatic mutations on phosphoethanolamine synthesis, ROS production and DNA damage

    Impact of ETNK1 somatic mutations on phosphoethanolamine synthesis, ROS production and DNA damage 由 Fontana, Diletta, Gambacorti-Passerini, Carlo, Piazza, Rocco

    出版 2021
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  4. 4
    Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia

    Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia 由 Fontana, Diletta, Gambacorti-Passerini, Carlo, Piazza, Rocco

    出版 2021
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  5. 5
    Synergistic Effects of Combined Wnt/KRAS Inhibition in Colorectal Cancer Cells

    Synergistic Effects of Combined Wnt/KRAS Inhibition in Colorectal Cancer Cells 由 Mologni, Luca, Brussolo, Stefania, Ceccon, Monica, Gambacorti-Passerini, Carlo

    出版 2012
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  6. 6
    Activity of second-generation ALK inhibitors against crizotinib-resistant mutants in an NPM-ALK model compared to EML4-ALK

    Activity of second-generation ALK inhibitors against crizotinib-resistant mutants in an NPM-ALK model compared to EML4-ALK 由 Fontana, Diletta, Ceccon, Monica, Gambacorti-Passerini, Carlo, Mologni, Luca

    出版 2015
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  7. 7
    The Novel PIM1 Inhibitor NMS-P645 Reverses PIM1-Dependent Effects on TMPRSS2/ERG Positive Prostate Cancer Cells And Shows Anti-Proliferative Activity in Combination with PI3K Inhibition

    The Novel PIM1 Inhibitor NMS-P645 Reverses PIM1-Dependent Effects on TMPRSS2/ERG Positive Prostate Cancer Cells And Shows Anti-Proliferative Activity in Combination with PI3K Inhib... 由 Mologni, Luca, Magistroni, Vera, Casuscelli, Francesco, Montemartini, Marisa, Gambacorti-Passerini, Carlo

    出版 2017
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  8. 8
    Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea

    Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea 由 Renso, Rossella, Aroldi, Andrea, Pioltelli, Pietro, Gambacorti-Passerini, Carlo, Elli, Elena Maria

    出版 2018
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  9. 9
    Locking Src/Abl Tyrosine Kinase Activities Regulate Cell Differentiation and Invasion of Human Cervical Cancer Cells Expressing E6/E7 Oncoproteins of High-Risk HPV

    Locking Src/Abl Tyrosine Kinase Activities Regulate Cell Differentiation and Invasion of Human Cervical Cancer Cells Expressing E6/E7 Oncoproteins of High-Risk HPV 由 Yasmeen, Amber, Alachkar, Amal, Dekhil, Hafedh, Gambacorti-Passerini, Carlo, Al Moustafa, Ala-Eddin

    出版 2010
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  10. 10
    An Imatinib–non‐responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization

    An Imatinib–non‐responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization 由 Crespiatico, Ilaria, Bossi, Elisa, Brioschi, Filippo, Piazza, Rocco, Mologni, Luca, Gambacorti‐Passerini, Carlo

    出版 2019
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  11. 11
    Increased sFLT‐1/PlGF ratio in COVID‐19: A novel link to angiotensin II‐mediated endothelial dysfunction

    Increased sFLT‐1/PlGF ratio in COVID‐19: A novel link to angiotensin II‐mediated endothelial dysfunction 由 Giardini, Valentina, Carrer, Andrea, Casati, Marco, Contro, Ernesto, Vergani, Patrizia, Gambacorti‐Passerini, Carlo

    出版 2020
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  12. 12
    Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes

    Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes 由 Sharma, Geeta Geeta, Mota, Ines, Mologni, Luca, Patrucco, Enrico, Gambacorti-Passerini, Carlo, Chiarle, Roberto

    出版 2018
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  13. 13
    Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study

    Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study 由 Cavalca, Fabrizio, Renso, Rossella, Zambrotta, Giovanni Paolo Maria, Gambacorti-Passerini, Carlo, Elli, Elena Maria

    出版 2021
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  14. 14
    FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery

    FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery 由 Piazza, Rocco, Pirola, Alessandra, Spinelli, Roberta, Valletta, Simona, Redaelli, Sara, Magistroni, Vera, Gambacorti-Passerini, Carlo

    出版 2012
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  15. 15
    NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922

    NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922 由 Mologni, Luca, Ceccon, Monica, Pirola, Alessandra, Chiriano, Gianpaolo, Piazza, Rocco, Scapozza, Leonardo, Gambacorti-Passerini, Carlo

    出版 2015
    获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  16. 16
    Mitochondrial Hyperactivation and Enhanced ROS Production are Involved in Toxicity Induced by Oncogenic Kinases Over-Signaling

    Mitochondrial Hyperactivation and Enhanced ROS Production are Involved in Toxicity Induced by Oncogenic Kinases Over-Signaling 由 Ceccon, Monica, Mauri, Mario, Massimino, Luca, Giudici, Giovanni, Piazza, Rocco, Gambacorti-Passerini, Carlo, Mologni, Luca

    出版 2018
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  17. 17
    VERSO: A comprehensive framework for the inference of robust phylogenies and the quantification of intra-host genomic diversity of viral samples

    VERSO: A comprehensive framework for the inference of robust phylogenies and the quantification of intra-host genomic diversity of viral samples 由 Ramazzotti, Daniele, Angaroni, Fabrizio, Maspero, Davide, Gambacorti-Passerini, Carlo, Antoniotti, Marco, Graudenzi, Alex, Piazza, Rocco

    出版 2021
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  18. 18
    Pregnancy outcomes in patients treated with bosutinib

    Pregnancy outcomes in patients treated with bosutinib 由 Cortes, Jorge E, Gambacorti-Passerini, Carlo, Deininger, Michael, Abruzzese, Elisabetta, DeAnnuntis, Liza, Brümmendorf, Tim H

    出版 2020
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  19. 19
    Dissection of the RET/β-catenin interaction in the TPC1 thyroid cancer cell line

    Dissection of the RET/β-catenin interaction in the TPC1 thyroid cancer cell line 由 Tartari, Carmen J, Donadoni, Carla, Manieri, Elisa, Mologni, Luca, Mina, Pamela Della, Villa, Antonello, Gambacorti-Passerini, Carlo

    出版 2011
    获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  20. 20
    BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene

    BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene 由 Sharma, Nitesh, Magistroni, Vera, Piazza, Rocco, Citterio, Stefania, Mezzatesta, Caterina, Khandelwal, Praveen, Pirola, Alessandra, Gambacorti-Passerini, Carlo

    出版 2015
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:

检索工具: